Conclusion
Since launching the new app in 2016, it has been downloaded more than 20,000 times and received excellent reviews and praise from the health community and especially from our clients.
The program that uses the app received:
Best Medical Digital Initiative for Consumers of 2016.
In addition, our process was so well received that our client now uses it as part of their framework for the development of their apps.
Pfizer follows up successful smoking cessation app with LivingWith, an app for cancer patients
"We can do surveys right in the app," Mark Pizzini, Pfizer's digital strategy lead, told MobiHealthNews.
"Fifty-seven percent of the people reported smoking less as a virtue of using the program. Sixty-four percent said they would recommend it to others. Those are two positive data points we’ve collected. Over 20,000 people downloaded the mobile app. There’s an online Facebook community of more than 170,000 people. All of this is very positive in the pharmaceutical space where the ability to do things like this is much more regulated and controlled."